Coronado Biosciences Inc (CNDO) Annual Balance Sheets

Annual · GAAP · USD millions
Access CNDO quarterly Balance Sheets →
Balance sheet data covering Coronado Biosciences Inc– offers a view into how Dec 31 2014's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2014)
(Dec 31 2013)
Assets
Cash & cash equivalent49.76
Marketable Securities, Current SH20.00
Cash & Short-term Investments69.00
Prepaid Expense And Other Assets Current0.70
Total Current Assets70.46
Equipment/Property/Plant Net0.05
Long-term investments4.16
Other Assets, Noncurrent14.66
Total Assets89.33
Liabilities
Accounts Payable, Current AC0.37
Accrued Liabilities, Current3.68
Notes Payable, Current NO0.00
Other Liabilities, Current0.03
Total Current Liabilities4.08
Long-term debt14.01
Total Long-term Debt14.01
Other liabilities, Noncurrent0.72
Total Liabilities18.81
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock212.21
Retained Earnings / Accumulated Deficit-141.73
Other Equity0.00
Common Stockholder's Equity70.52
Total Stockholder's Equity70.52
Liabilities & Stockholder's Equity89.33
4 historic quarters locked

Sign in to unlock the full Coronado Biosciences Inc balance sheet history.

About Fortress Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037874

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License